CLN6

Clinical trials for CLN6 explained in plain language.

Never miss a new study

Get alerted when new CLN6 trials appear

Sign up with your email to follow new studies for CLN6, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 1

Gene therapy for rare brain disease tracked over years

Disease control Ongoing

This study follows 10 people with CLN6 Batten disease who received a single dose of gene therapy (AT-GTX-501) in an earlier trial. Researchers are checking long-term safety and how the disease progresses over time. No new treatment is given in this follow-up.

Matched conditions: CLN6

Sponsor: Emily de los Reyes • Aim: Disease control

Last updated Jun 27, 2026 07:52 UTC

CLN6

Get alerted when new CLN6 trials appear

Gene therapy for rare brain disease tracked over years